NULASTIN, Inc. – Trademark Portfolio
Entity Type: 03
NULASTIN, Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 15 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 8 trademarks are registered and 3 are pending. Notable registered marks include NULASTIN, REGENATEZ, ELASTAPLEX, FORTICELLE, and N NULASTIN. The owner is based in Boulder, CO.
PO Box 7557
Boulder, CO 80306
Showing of trademarks Trademarks
Trademark Classifications
NULASTIN, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NULASTIN, Inc. have?
NULASTIN, Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 8 registered, 3 pending, 6 abandoned.
What trademark classes does NULASTIN, Inc. file in?
NULASTIN, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are NULASTIN, Inc.'s most well-known trademarks?
NULASTIN, Inc.'s registered trademark portfolio includes well-known marks such as NULASTIN, REGENATEZ, ELASTAPLEX, FORTICELLE, and N NULASTIN. These are among 8 currently registered trademarks in the portfolio.
What is NULASTIN, Inc.'s trademark registration success rate?
NULASTIN, Inc. has a 57% trademark registration rate, with 8 out of 14 resolved applications resulting in successful registration. Currently, 3 applications are pending review.